Skip to main content
UAB - The University of Alabama at Birmingham
admin login frontend login
Alabama Coalition for Testing, Interventions, and Engagement in HCV Care
Heersink School of Medicine
  • UAB Quicklinks
      • UAB Home
      • Academic Calendar
      • Accessibility
      • Apply
      • AskIT
      • Blazer Express
      • BlazerNET
      • BlazerPulse
      • Bookstore
      • Campus Calendar
      • Campus Map
      • Canvas
      • Departments
      • Directory
      • Email
      • Emergency/B-Alert
      • Employee Resources
      • Employment
      • MyUAB Employee Portal
      • Giving to UAB
      • TechConnect
      • UAB eLearning
      More Items
 
  • About Us
    • Mission
    • Network Map
    • Meet the Team
  • Providers
    • Statement of the Problem
    • CDC Testing Guidelines
    • Treatment Options
    • Provider Trainings
    • MIST Line
    • Referral Process
  • Patient Information
    • What is Hepatitis C Virus?
    • Am I at Risk?
    • Evaluation and Treatment Options
    • Managing Side Effects
    • ACTIVE-C Testing and Treatment Locations
  • Sharepoint Site
ActiveC Title.fw

What is Hepatitis C Virus?

Hepatitis C is an infection caused by a virus. The virus causes inflammation of the liver, which is swelling that occurs when the body's tissues are injured or infected. There are two types of Hepatits C: acute and chronic. Acute Hepatitis lasts only a few weeks to months. Chronic Hepatitis lasts longer than 6 months. 


Who Should be Tested?

Who should be tested for HCV infection? 
  • All individuals born between 1945 through 1965
  • Those who received/donated blood, blood products, or organ transplants before 1992
  • All individuals with HIV infection
  • People who have undergone dialysis 
  • Healthcare workers exposed to blood
  • Individuals who got tattoos or body piercings under nonsterile conditions 
  • People who share equipment to snort or inhale drugs (e.g cocaine)
  • People who inject drugs (PWID) past or current
  • Individuals born to a mother with Hepatitis C infection
  • People who participate in cultural practices such as bloodletting and male/female circumcision
  • Those who were vaccinated in the past as part of a mass vaccination effort outside of the United States (eg, Egypt and India)


Evaluation and Treatment Options

How is Hepatitis C Diagnosed? 
The Hepatitis C Antibody Test detects whether your immune system has been exposed to Hepatitis C. If the Antibody test is positive, other tests will be needed to confirm diagnosis and treatment. 


How is the Treatment Regimen Determined? 
Treatment regimen is determined by genotype testing, lab values, diagnostic reports, and previous treatment. Genotype 1 is the most common in the United States. The genotype helps your provider determine the type and length of your treatment. In the United States, more than 3 out of 4 people who have Hepatitis C have genotype 1.
 
  • Contact UAB
  • |
  • |
  • A-Z Site Index
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2023 The University of Alabama at Birmingham
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.